octriptyline

{{Short description|Chemical compound}}

{{cs1 config|name-list-style=vanc}}

{{Drugbox

| image = Octriptyline.png

| width = 200

| alt = Chemical structure of Octriptyline

| tradename =

| pregnancy_category =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number = 47166-67-6

| CAS_supplemental =
{{CAS|51481-67-5}} (phosphate salt)

| ATC_prefix =

| ATC_suffix =

| PubChem = 40029

| ChemSpiderID = 36588

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = C3X0UOC25D

| ChEMBL = 2110951

| IUPAC_name = N-methyl-3-(11-tetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaenylidene)propan-1-amine

| C=20 | H=21 | N=1

| SMILES = CNCCC=C1C2=CC=CC=C2C3CC3C4=CC=CC=C41

| StdInChI = 1S/C20H21N/c1-21-12-6-11-16-14-7-2-4-9-17(14)19-13-20(19)18-10-5-3-8-15(16)18/h2-5,7-11,19-21H,6,12-13H2,1H3

| StdInChIKey = MILRTYCRJIRPKY-UHFFFAOYSA-N

}}

Octriptyline (SC-27,123) is a tricyclic antidepressant (TCA) that was never marketed.{{cite book | url = https://books.google.com/books?id=A0THacd46ZsC&q=%22SC-27%2C123%22+octriptyline&pg=PA1469 | title = Dictionary of pharmacological agents - Google Books| isbn = 9780412466304| vauthors = Ganellin CR, Triggle DJ | date = 21 November 1996| publisher = CRC Press}}{{Cite patent|country=GB|number=1406481|pubdate=1975-09-17|title=Dibenzocycloheptene compounds|assign1=John Wyeth & Brother Ltd.}}